274 related articles for article (PubMed ID: 18971403)
1. Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*D.
Lesser I; Rosales A; Zisook S; Gonzalez C; Flores D; Trivedi M; Sciolla A; Luther J; Wisniewski S; Alpert J; Cook I; Rush AJ; Epstein M
Psychiatr Serv; 2008 Nov; 59(11):1273-84. PubMed ID: 18971403
[TBL] [Abstract][Full Text] [Related]
2. Ethnicity/race and outcome in the treatment of depression: results from STAR*D.
Lesser IM; Castro DB; Gaynes BN; Gonzalez J; Rush AJ; Alpert JE; Trivedi M; Luther JF; Wisniewski SR
Med Care; 2007 Nov; 45(11):1043-51. PubMed ID: 18049344
[TBL] [Abstract][Full Text] [Related]
3. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Rush AJ; Wisniewski SR; Warden D; Luther JF; Davis LL; Fava M; Nierenberg AA; Trivedi MH
Arch Gen Psychiatry; 2008 Aug; 65(8):870-80. PubMed ID: 18678792
[TBL] [Abstract][Full Text] [Related]
4. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
Rush AJ; Wisniewski SR; Zisook S; Fava M; Sung SC; Haley CL; Chan HN; Gilmer WS; Warden D; Nierenberg AA; Balasubramani GK; Gaynes BN; Trivedi MH; Hollon SD
Psychol Med; 2012 Jun; 42(6):1131-49. PubMed ID: 22008447
[TBL] [Abstract][Full Text] [Related]
5. SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
Shiroma PR; Drews MS; Geske JR; Mrazek DA
Am J Geriatr Psychiatry; 2014 Nov; 22(11):1140-8. PubMed ID: 23973251
[TBL] [Abstract][Full Text] [Related]
6. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
[TBL] [Abstract][Full Text] [Related]
7. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Gaynes BN; Dusetzina SB; Ellis AR; Hansen RA; Farley JF; Miller WC; Stürmer T
J Clin Psychopharmacol; 2012 Feb; 32(1):114-9. PubMed ID: 22198447
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
Rush AJ; Bernstein IH; Trivedi MH; Carmody TJ; Wisniewski S; Mundt JC; Shores-Wilson K; Biggs MM; Woo A; Nierenberg AA; Fava M
Biol Psychiatry; 2006 Mar; 59(6):493-501. PubMed ID: 16199008
[TBL] [Abstract][Full Text] [Related]
9. Trajectories of individual symptoms in remitters versus non-remitters with depression.
Sakurai H; Uchida H; Abe T; Nakajima S; Suzuki T; Pollock BG; Sato Y; Mimura M
J Affect Disord; 2013 Nov; 151(2):506-513. PubMed ID: 23886402
[TBL] [Abstract][Full Text] [Related]
10. Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant.
Katz AJ; Dusetzina SB; Farley JF; Ellis AR; Gaynes BN; Castillo WC; Stürmer T; Hansen RA
Pharmacotherapy; 2012 Mar; 32(3):234-43. PubMed ID: 22392456
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in response to citalopram: a STAR*D report.
Young EA; Kornstein SG; Marcus SM; Harvey AT; Warden D; Wisniewski SR; Balasubramani GK; Fava M; Trivedi MH; John Rush A
J Psychiatr Res; 2009 Feb; 43(5):503-11. PubMed ID: 18752809
[TBL] [Abstract][Full Text] [Related]
12. Income and attrition in the treatment of depression: a STAR*D report.
Warden D; Rush AJ; Wisniewski SR; Lesser IM; Thase ME; Balasubramani GK; Shores-Wilson K; Nierenberg AA; Trivedi MH
Depress Anxiety; 2009; 26(7):622-33. PubMed ID: 19582825
[TBL] [Abstract][Full Text] [Related]
13. Depression and quality of life in Spanish-speaking immigrant persons with epilepsy compared with those in English-speaking US-born persons with epilepsy.
Myers L; Lancman M; Vazquez-Casals G; Bonafina M; Perrine K; Sabri J
Epilepsy Behav; 2015 Oct; 51():146-51. PubMed ID: 26277451
[TBL] [Abstract][Full Text] [Related]
14. Enhancing Hispanic participation in mental health clinical research: development of a Spanish-speaking depression research site.
Aponte-Rivera V; Dunlop BW; Ramirez C; Kelley ME; Schneider R; Blastos B; Larson J; Mercado F; Mayberg H; Craighead WE
Depress Anxiety; 2014 Mar; 31(3):258-67. PubMed ID: 23959771
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D Report.
Shelton RC; Hollon SD; Wisniewski SR; Alpert JE; Balasubramani GK; Friedman ES; Rush AJ; Trivedi MH; Preskorn SH
CNS Spectr; 2009 Sep; 14(9):487-98. PubMed ID: 19890231
[TBL] [Abstract][Full Text] [Related]
16. Quality of Life and Functioning in Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder After Treatment With Citalopram Monotherapy.
Steiner AJ; Boulos N; Mirocha J; Wright SM; Collison KL; IsHak WW
Clin Neuropharmacol; 2017; 40(1):16-23. PubMed ID: 27764051
[TBL] [Abstract][Full Text] [Related]
17. Diurnal mood variation in outpatients with major depressive disorder.
Morris DW; Trivedi MH; Fava M; Wisniewski SR; Balasubramani GK; Khan AY; Jain S; Rush AJ
Depress Anxiety; 2009; 26(9):851-63. PubMed ID: 19306304
[TBL] [Abstract][Full Text] [Related]
18. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
Nierenberg AA; Husain MM; Trivedi MH; Fava M; Warden D; Wisniewski SR; Miyahara S; Rush AJ
Psychol Med; 2010 Jan; 40(1):41-50. PubMed ID: 19460188
[TBL] [Abstract][Full Text] [Related]
19. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
Leuchter AF; Husain MM; Cook IA; Trivedi MH; Wisniewski SR; Gilmer WS; Luther JF; Fava M; Rush AJ
Psychol Med; 2010 Feb; 40(2):239-51. PubMed ID: 19493369
[TBL] [Abstract][Full Text] [Related]
20. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD.
Cohen RM; Greenberg JM; IsHak WW
JAMA Psychiatry; 2013 Mar; 70(3):343-50. PubMed ID: 23303512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
